OpenAI CEO Sam Altman surprised the tech world on Thursday with the launch of Operator, his company’s first AI agent that can ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...

Musk’s criticisms have escalated into legal actions. In February, he filed a lawsuit against OpenAI, accusing it of breaching ...

About 875 acres in Abilene, or roughly the size of New York’s Central Park, have been set aside to construct data centers, ...

Sam Altman, the CEO of OpenAI, now says he is more confident of a fast AI takeoff. A fast AI takeoff is more possible than he ...

It’s a major get for Murati’s mysterious startup, which has also poached engineers and researchers from a number of other ...

According to a recent research report from Goldman Sachs, AI could boost global growth by 7% over the next decade, boost S&P ...

OpenAI, Oracle and SoftBank have come together for this USD 500 billion project announced by US President Donald Trump ...